Latest News and Press Releases

  Arvelle Announces Partnership with Durbin Across Europe Zug, Switzerland, 17 August 2020 – Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to...

Arvelle Announces Closing of Final Tranche of Series A Financing Round  Brings the total financing to $207.8m Triggered by successful filing and validation of the MAA for cenobamate Zug,...

Arvelle Announces Closing of Final Tranche of Series A Financing Round  Brings the total financing to $207.8m Triggered by successful filing and validation of the MAA for cenobamate Zug,...

SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy-          Arvelle Therapeutics has...

Appointment of Dr Otto Schwarz as Independent Director and Chairman of the Board Zug, Switzerland, December 4, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company...

Arvelle to Present at Jefferies 2019 London Healthcare Conference Zug, Switzerland, November 15, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company focused on...

Arvelle Therapeutics Strengthens Management Team with Key New Hires Appoints Petra Molan as Senior Vice President Commercial and                                                   Enrico Dolfini as...